CHINASOFT INT'L (00354) Chairman and Executive Director Chen Yuhong has increased his holdings by 1 million shares.
China Software International (00354) announced that on April 1, 2026, the company received notification from its major shareholder, Chairman and Executive Director Dr. Chen Yuhong. Dr. Chen purchased a total of 1 million ordinary shares of the company on the open market on April 1, 2026, at an average price of approximately HK$3.4287 per share, with a total amount of approximately HK$3.4287 million. The total number of ordinary shares acquired through the equity increase is equivalent to approximately 0.04% of the total number of shares issued by the company as of the date of this announcement. Following the equity increase, Dr. Chen holds 325 million shares, equivalent to approximately 11.90% of the total number of shares issued by the company as of the date of this announcement.
CHINASOFT INT'L(00354) announced that on April 1, 2026, the company's major shareholder, Chairman and Executive Director, Dr. Chen Yuhong, notified that Dr. Chen had purchased a total of 1 million shares of the company's common stock on the open market on April 1, 2026, at an average price of approximately HK$3.4287 per share, totaling approximately HK$3.4287 million. The total number of common shares acquired through the equity increase is equivalent to approximately 0.04% of the total number of shares issued by the company on the date of this announcement. Following the equity increase, Dr. Chen holds 325 million shares, equivalent to approximately 11.90% of the total number of shares issued by the company on the date of this announcement.
Related Articles

Shenzhen Kangtai Biological Products (300601.SZ): Tetanus vaccine receives drug registration certificate

Zhejiang Huahai Pharmaceutical (600521.SH): Mesalazine enteric-coated tablets obtain drug registration certificate.

HAITONG INT'L: Find certainty in essential consumption, focus on beer, dairy and other sectors.
Shenzhen Kangtai Biological Products (300601.SZ): Tetanus vaccine receives drug registration certificate

Zhejiang Huahai Pharmaceutical (600521.SH): Mesalazine enteric-coated tablets obtain drug registration certificate.

HAITONG INT'L: Find certainty in essential consumption, focus on beer, dairy and other sectors.

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


